2020
DOI: 10.1039/c9dt04024b
|View full text |Cite
|
Sign up to set email alerts
|

Towards dual SPECT/optical bioimaging with a mitochondrial targeting, 99mTc(i) radiolabelled 1,8-naphthalimide conjugate

Abstract: Highly fluorescent naphthalimide fluorophores can be radiolabelled with Tc(i)-99m for bimodal bioimaging applications.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 54 publications
0
2
0
Order By: Relevance
“…Pyridyl triazole scaffolds [73], imidazole derivatives [74] and porphyrin [75] have been involved in heterobimetallic coordination. Recently, Day et al reported a tracer combining the naphtalimide fluorophore and a picolylamine chelator [76]. Around 55% RCY was achieved after fac-[ 99m Tc (CO) 3 (H 2 O) 3 ] + radiolabelling.…”
Section: Metal-based Systemsmentioning
confidence: 99%
“…Pyridyl triazole scaffolds [73], imidazole derivatives [74] and porphyrin [75] have been involved in heterobimetallic coordination. Recently, Day et al reported a tracer combining the naphtalimide fluorophore and a picolylamine chelator [76]. Around 55% RCY was achieved after fac-[ 99m Tc (CO) 3 (H 2 O) 3 ] + radiolabelling.…”
Section: Metal-based Systemsmentioning
confidence: 99%
“…The design and synthesis of stable and kinetically inert fac -[M­(CO) 3 ] + (M = 99m Tc/ 186/188 Re) core-based complexes have been gaining continuous research interest for the development of new radiopharmaceuticals as diagnostic and therapeutic agents. 99m Tc is still the workhorse of nuclear diagnostics because of its ideal nuclear decay properties ( t 1/2 = 6.02 h, pure γ emitter, and E γ = 140 keV, 89%), whereas the β-emitting rhenium nuclides 188 Re ( t 1/2 = 17 h and E β = 2.12 MeV) and 186 Re ( t 1/2 = 89.3 h and E β = 1.07 MeV) have potential for therapy . Isostructural technetium and rhenium complexes are good candidates for nuclear medical theranostics, and procedures exist for the synthesis of aqua complexes [ 99m Tc/ 188 Re­(CO) 3 (H 2 O) 3 ] + as appropriate precursor molecules. ,,, Several attempts have been made toward the synthesis of organometallic technetium complexes using various types of heterocyclic ligands because of their importance in medicinal fields. Recently, efforts have been directed toward the design and synthesis of fac -[Re­(CO) 3 ] + core-based metal–organic macrocycles, i.e., supramolecular coordination complexes or metallomacrocycles, because of their potential applications as bioimaging and anticancer agents. …”
mentioning
confidence: 99%